Revenu Net Changement Date
Akebia Therapeutics USD -12.24M 12.78M 2025-12
Alnylam Pharmaceuticals USD 164.49M 41.5M 2026-06
Celltrion KRW 8.82B 64.74M 2026-03
Cspc Pharmaceutical CNY 370.72M 592.81M 2025-12
Deva Holding AS TRY 583.98M 319.1M 2023-09
Dianthus Therapeutics USD -40.83M 23.6M 2026-03
Divis Laboratories Ltd INR 9.02B 1.51B 2026-06
Gilead Sciences USD -10.5B 12.52B 2026-06
Ionis Pharmaceuticals USD -114.65M 21.65M 2026-06
Kangmei Pharma CNY -16.56M 12.74M 2026-03
Karyopharm Therapeutics USD -22.39M 79.81M 2026-03
Knight Therapeutics CAD -3.79M 8.83M 2025-09
Laboratorios Farma EUR 103.69M 37.04M 2023-12
MacroGenics USD -36.77M 22.62M 2026-03
Malin Corporation EUR -1.1M 2.2M 2023-12
Medical Developments International AUD -226K 121K 2025-12
Neuren Pharmaceuticals AUD 15.4M 7.88M 2025-12
Organigram Holdings CAD -921K 20.89M 2026-03
Ovoca Bio EUR 4.42M 5.19M 2025-12
Pfizer USD -248M 2.94B 2026-06
Pharma Mar EUR -972K 2.5M 2026-06
Qiagen NV USD 68.04M 39.79M 2026-03
Roche Holding CHF 6.87B 1.4B 2026-06
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Sanofi EUR 343M 1.27B 2026-06
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
Sartorius EUR 65.9M 9.7M 2026-06
Sino Biopharmaceutical CNY 3.39B 2.91B 2025-06
Takeda JPY 113.2B 137.52B 2026-06
Tilray USD -44.93M 44.61M 2025-09
Zealand Pharma A/S -394M 14.88M 2026-03
Zz Pientze Pharmaceu CNY 743.48M 56.45M 2026-03